Though New Hampshire's Legislature has made tackling the state's opioid abuse crisis a priority, lawmakers also get a sizable share of their campaign cash from prescription drug companies.

A joint investigation by The Associated Press and the Center for Public Integrity found that drug companies and allied advocates spent more than $880 million on lobbying and political contributions over the past decade.

A coalition of companies and advocacy groups that meets regularly to discuss opioid-related issues contributed $231,110 to state candidates and parties in New Hampshire between 2006 and 2015.

Most other states received significantly more from members of the Pain Care Forum, but New Hampshire ranked ninth in terms of the share of total contributions that money represents.